Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study
International Journal of Clinical Oncology · 2025
DOI: 10.1007/s10147-025-02810-5 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Clinical Oncology, 2025. Verfasst von Keisuke Okamoto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Laboratory of Clinical Pharmaceutics and Therapeutics, Division of Pharmasciences, Hokkaido University, Kita-12-J…. Hauptthemen laut MEDLINE: Celecoxib, Cisplatin, Lung Neoplasms, Cyclooxygenase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, Laboratory of Clinical Pharmaceutics and Therapeutics, Division of Pharmasciences, Hokkaido University, Kita-12-Jo, Nishi-6-Chome, Kita-Ku, Sapporo, 060-0812, Japan.
- Faculty of Pharmaceutical Sciences, Department of Clinical Pharmaceutics and Therapeutics, Hokkaido University of Science, 4-1, Maeda 7-Jo 15-Chome, Teine-Ku, Sapporo, 006-8585, Japan. yossypma@med.hokudai.ac.jp.
- Department of Pharmacy, NTT Medical Center Sapporo, Minami 1-Jo, Nishi 15-Chome, Chuo-Ku, Sapporo, 060-0061, Japan.
- Department of Pharmacy, Hokkaido University Hospital, Kita-14-Jo, Nishi-5-Chome, Kita-Ku, Sapporo, 060-8648, Japan.
- Faculty of Medicine, Department of Respiratory Medicine, Hokkaido University, Kita 15-Jo, Nishi 7-Chome, Kita-Ku, Sapporo, 060-8638, Japan.
- Faculty of Pharmaceutical Sciences, Education Research Center for Clinical Pharmacy, Hokkaido University, Kita-12-Jo, Nishi-6-Chome, Kita-Ku, Sapporo, 060-0812, Japan.
Zitieren
APA
Okamoto, K., Saito, Y., Takahashi, K., Takekuma, Y., Sakakibara-Konishi, J., Narumi, K., Sugawara, M., & Kobayashi, M. (2025). Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-025-02810-5
Vancouver
Okamoto K, Saito Y, Takahashi K, Takekuma Y, Sakakibara-Konishi J, Narumi K, et al. Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study. International Journal of Clinical Oncology. 2025. doi:10.1007/s10147-025-02810-5
BibTeX
@article{Okamoto2025,
author = {Okamoto, Keisuke and Saito, Yoshitaka and Takahashi, Kenta and Takekuma, Yoh and Sakakibara-Konishi, Jun and Narumi, Katsuya and Sugawara, Mitsuru and Kobayashi, Masaki},
title = {Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study},
journal = {International Journal of Clinical Oncology},
year = {2025},
doi = {10.1007/s10147-025-02810-5}
}
EUVIMED